- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00707668
Chung-ju Metabolic Disease Cohort (CMC) Study
July 25, 2014 updated by: Kun-Ho Yoon, The Catholic University of Korea
This is an observational study on the prevalence and incidence of diabetes and osteoporosis in a rural area of Korea.
Study Overview
Status
Unknown
Conditions
Detailed Description
Diabetes, metabolic syndrome and dyslipidemia are common and rapidly increasing in Asia.
Our group constructed a cohort in Chung-ju city, a rural area in Korea, to observe the prevalence of metabolic diseases and its risk factors since 2003.
About 12,000 subjects participated in this cohort study till 2006.
Now, we are planning to follow-up these subjects and provide health examinations from May, 2007 to Feb, 2011.
The prevalence and incidence of metabolic diseases including diabetes, hypertension, metabolic syndrome, dislipidemia and osteoporosis will be observed.
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kun-Ho Yoon, M.D., Ph.D.
- Phone Number: 82-2-590-1402
- Email: yoonk@catholic.ac.kr
Study Contact Backup
- Name: Seung-Hwan Lee, M.D.
- Phone Number: 82-2-590-1422
- Email: hwanx2@catholic.ac.kr
Study Locations
-
-
Chungchungbook-do
-
Chung-ju, Chungchungbook-do, Korea, Republic of
- Recruiting
- Chung-ju health care center
-
Sub-Investigator:
- Seung-Hwan Lee, M.D.
-
Contact:
- Seung D Shin, RN
- Phone Number: 82-43-850-7349
- Email: ssdeug@naver.com
-
Principal Investigator:
- Ho-Young Son, M.D.,Ph.D.
-
Sub-Investigator:
- Won-chul Lee, M.D., Ph.D
-
Sub-Investigator:
- Hyun-Woo Yim, M.D., Ph.D.
-
Sub-Investigator:
- Moo-Il Kang, M.D., Ph.D.
-
Sub-Investigator:
- Hyuk-Sang Kwon, M.D., Ph.D.
-
Sub-Investigator:
- Ki-Hyun Baik, M.D., Ph.D.
-
Sub-Investigator:
- Yong-Moon Park, M.D., Ph.D.
-
Sub-Investigator:
- Jin-Hee Lee, Ph.D.
-
Sub-Investigator:
- Young-Jun Park, M.D.
-
Sub-Investigator:
- Mi-Kyung Kim, M.D.
-
Sub-Investigator:
- Hee-Seung Ha
-
Sub-Investigator:
- Hyun-Bin Kim
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adults over 30 years of age living in Chung-ju city
Description
Inclusion Criteria:
- Adults over 30 years of age living in Chung-ju city (who participated in 2003-2006 cohort study)
Exclusion Criteria:
- age under 30
- subjects with known diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control
Chung-ju cohort populations aged over 30 year-old
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The incidence of diabetes
Time Frame: 4 years
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The prevalence of metabolic syndrome, dyslipidemia and osteoporosis
Time Frame: 4 years
|
4 years
|
Insulin sensitivity and resistance of Korean subjects
Time Frame: 4 years
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kun-Ho Yoon, M.D., Ph.D., Kangnam St.Mary's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2007
Primary Completion (Anticipated)
February 1, 2016
Study Completion (Anticipated)
February 1, 2016
Study Registration Dates
First Submitted
June 27, 2008
First Submitted That Met QC Criteria
June 27, 2008
First Posted (Estimate)
July 1, 2008
Study Record Updates
Last Update Posted (Estimate)
July 28, 2014
Last Update Submitted That Met QC Criteria
July 25, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KCMC07OT076
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Diseases
-
Mondelēz International, Inc.University of SydneyCompletedMetabolic DisorderAustralia
-
Asia UniversityDepartment of Health, Executive Yuan, R.O.C. (Taiwan)Completed
-
Hospital Clinic of BarcelonaNovartisCompletedBone Disease, MetabolicSpain
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Stichting MetakidsCompletedInherited Metabolic DisordersNetherlands
-
San Diego State UniversityRecruitingBone Disease, MetabolicUnited States
-
Nantes University HospitalCentre de Recherche en Nutrition Humaine Ouest (CRNH)CompletedCholesterol; Metabolic Disorder | LipoproteinemiaFrance
-
Istituto Ortopedico RizzoliCompletedOsteopenia | Bone Disease, MetabolicItaly
-
Mondelēz International, Inc.University of SydneyCompletedMetabolic Disorder; Carbohydrate, Absorption, IntestineAustralia
-
PharmanexUtah State University; Texas Diabetes & Endocrinology, P.A.CompletedOther Endocrine/Nutritional/Metabolic DisorderUnited States